Skip to main content
. Author manuscript; available in PMC: 2016 Aug 11.
Published in final edited form as: Arch Pharm (Weinheim). 2013 Jan;346(1):23–33. doi: 10.1002/ardp.201200334

Table 4.

IC50 (μm)a) of the most active tetrahydro-β-carboline-hydantoins and tadalafil against an array of PDEs.

Compound PDE1A cGMP PDE2A cGMP PDE3A cGMP PDE5A cGMP PDE9A cGMP PDE10A cGMP PDE11A cGMP PDE11A cAMP Selectivity index IC50 (PDE11A/PDE5A) cGMP/cGMP
8 >50 >50 >50 0.16 >50 >50 7.8 11.3 49
9 >50 >50 >50 0.17 >50 >50 2.3 4 14
Tadalafil >50 >50 >50 0.004 >50 >50 0.05 0.3 13
a)

Calculated from 10 concentrations, each with double replicates.